The price at this company is trading is ridiculous. I'm perplexed as some of you as to why someone in the Bio industry doesn't gobble this up. Do they not see potential of the pipeline? They could potentially make billions. If Genta got financing from a Bio firm, then they would not need to do the R/S or resort to 'toxic financing' and further dilution. Seems logical to me, but I can only see the top of the ice-burg.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.